Press release
US & Canada Beta Glucan Market Comprehensive Analysis 2020 | Size, Share, Trend, Future Strategic Planning, Current Scenario, Gross Margin and Forecast to 2027
Beta Glucan Market
US & Canada Beta Glucan Market will register the CAGR of more than 6.1% during the forecast period.
Developing interest for nutraceutical and functional product is found in the most recent decade. This happened because of quick way of life and idea of curing illness through food. Individuals everywhere throughout the world have a mission for new choices and idea of functional ingredients fulfill their dietary needs as these positively affect metabolic parameters and eventually supportive in diseases, for example, cancer, diabetes and cardiovascular disease. Beta Glucan is a significant functional ingredient that has various medical advantages.
Get Free Sample Copy of "US & Canada Beta Glucan Market" @ https://www.marketresearchfuture.com/sample_request/689
The general purpose of beta glucan is to enhance and improve the human immune system. Currently, people are getting more aware and conscious about health food intake and boost their immune system, while performing these activities the demand of Beta-Glucan has increased globally.
The global beta glucan industry reached US$ XX Million in 2016, marking an annual increase of 15% from 2014, majorly driven by increase in nutritional supplements. Globally, Western Europe (France, Spain, Italy, U.K, Germany and others) dominates the beta glucan industry, while North America is the second largest market for beta glucan industry. In North America, the US acquires the greater part of the beta-glucan market and captures XX% of the market as compared to Canada. The US market was estimnated US$ XX Million in 2014 and is anticipated to reach US$ XX Million in 2016.
Key Players
The prominent players present in the US & Canada Beta Glucan Market includes Lesaffre USA, DSM USA, Bio Springer, Lallemand, Associated British Foods, Biothera Inc, Tate & Lyle, Garuda International Inc, Alltech, Ceapro Inc, Super Beta glucan, ConAgra Foods, Inc, Cargill and others.
The strategy adopted by DSM is that working with its own clients and customers to create awareness and mindfulness amongst customers of the advantages of oat beta-glucan and the Friend OatWell brand has been created to convey the advantages on buyer product bundling. OatWell is accessible in flour or powder design, reasonable for use in applications running from breads, biscuits and oats to pasta, refreshments, instant powder drinks and dietary supplements. The other players’ strategies are also discussed in the report.
Access Report @ https://www.marketresearchfuture.com/reports/beta-glucan-market-689
Research Methodology
To calculate US & Canada beta glucan market size, MRFR has considered prominent players in the in the US & Canada market and to offer accuracy, our research is supported by industry experts who offer insight on industry structure and technology assessment, competitive landscape, penetration, emerging products and trends. MRFR analysis is based (80 to 85%) on primary & (15 to 20%) on secondary research as well as years of professional expertise in their respective industries.
Contact
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US & Canada Beta Glucan Market Comprehensive Analysis 2020 | Size, Share, Trend, Future Strategic Planning, Current Scenario, Gross Margin and Forecast to 2027 here
News-ID: 2089860 • Views: …
More Releases from Market Research Future
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Beta
Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034.
Exactitude Consultancy., Ltd. released a research report…
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR).
Market Dynamics and Growth Drivers
Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable…
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much!
Apuem
Finkenhofstraße 27
60322 Frankfurt am Main
Germany
Jacob Kearson
support@apuem.com
More Information: apuem.com/contact
We and our community search for the best web apps…
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018.
Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427
Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit…
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026.
Heat exchangers are devices that transfer energy between fluids…
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Beta-lactam and Beta-lactamase…
